3rd Quarter - Report

FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC

Firm
Client
Income
—
Expenses
$75,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Pharmaceutical supply chain and API procurement, Global drug shortages, Tax reform

LobbyistCovered position, as disclosed
TIMOTHY CASEY Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE Congressman Tom Davis

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Patent & Trademark Office (PTO); Food & Drug Administration (FDA)

Pharmacy PHA

Rebate reform, any willing pharmacy, PBMs, IRA Medicare Direct Negotiation, DIR fees

LobbyistCovered position, as disclosed
TIMOTHY CASEY Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE Congressman Tom Davis

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Medicare/Medicaid MMM

IRA, Part D redesign, rebates, AMP CAP, inflationary penalties, mid-year formulary changes

LobbyistCovered position, as disclosed
TIMOTHY CASEY Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE Congressman Tom Davis

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

Tax incentives for American production of pharmaceutical product, opioid taxes

LobbyistCovered position, as disclosed
TIMOTHY CASEY Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE Congressman Tom Davis

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.